143 related articles for article (PubMed ID: 38083903)
1. Profiling regulatory T lymphocytes within the tumor microenvironment of breast cancer via radiomics.
Jiang W; Wu R; Yang T; Yu S; Xing W
Cancer Med; 2023 Dec; 12(24):21861-21872. PubMed ID: 38083903
[TBL] [Abstract][Full Text] [Related]
2. Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes.
Arefan D; Hausler RM; Sumkin JH; Sun M; Wu S
BMC Cancer; 2021 Apr; 21(1):370. PubMed ID: 33827490
[TBL] [Abstract][Full Text] [Related]
3. MRI-based Machine Learning Radiomics Can Predict CSF1R Expression Level and Prognosis in High-grade Gliomas.
Lai Y; Wu Y; Chen X; Gu W; Zhou G; Weng M
J Imaging Inform Med; 2024 Feb; 37(1):209-229. PubMed ID: 38343263
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
5. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging-based radiomics was used to evaluate the level of prognosis-related immune cell infiltration in breast cancer tumor microenvironment.
Qian H; Ren X; Xu M; Fang Z; Zhang R; Bu Y; Zhou C
BMC Med Imaging; 2024 Feb; 24(1):31. PubMed ID: 38308230
[TBL] [Abstract][Full Text] [Related]
7. Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer.
Su GH; Xiao Y; Jiang L; Zheng RC; Wang H; Chen Y; Gu YJ; You C; Shao ZM
J Transl Med; 2022 Oct; 20(1):471. PubMed ID: 36243806
[TBL] [Abstract][Full Text] [Related]
8. MRI-based radiomic models to predict surgical margin status and infer tumor immune microenvironment in breast cancer patients with breast-conserving surgery: a multicenter validation study.
Ma J; Chen K; Li S; Zhu L; Yu Y; Li J; Ma J; Ouyang J; Wu Z; Tan Y; He Z; Liu H; Pan Z; Li H; Liu Q; Song E
Eur Radiol; 2024 Mar; 34(3):1774-1789. PubMed ID: 37658888
[TBL] [Abstract][Full Text] [Related]
9. Exploration of a noninvasive radiomics classifier for breast cancer tumor microenvironment categorization and prognostic outcome prediction.
Han X; Gong Z; Guo Y; Tang W; Wei X
Eur J Radiol; 2024 Jun; 175():111441. PubMed ID: 38537607
[TBL] [Abstract][Full Text] [Related]
10. Radiomics Based on T2-Weighted Imaging and Apparent Diffusion Coefficient Images for Preoperative Evaluation of Lymph Node Metastasis in Rectal Cancer Patients.
Li C; Yin J
Front Oncol; 2021; 11():671354. PubMed ID: 34041033
[TBL] [Abstract][Full Text] [Related]
11. Radiomics Model for Evaluating the Level of Tumor-Infiltrating Lymphocytes in Breast Cancer Based on Dynamic Contrast-Enhanced MRI.
Xu N; Zhou J; He X; Ye S; Miao H; Liu H; Chen Z; Zhao Y; Pan Z; Wang M
Clin Breast Cancer; 2021 Oct; 21(5):440-449.e1. PubMed ID: 33795199
[TBL] [Abstract][Full Text] [Related]
12. Radiomics features on ultrasound imaging for the prediction of disease-free survival in triple negative breast cancer: a multi-institutional study.
Yu F; Hang J; Deng J; Yang B; Wang J; Ye X; Liu Y
Br J Radiol; 2021 Oct; 94(1126):20210188. PubMed ID: 34478336
[TBL] [Abstract][Full Text] [Related]
13. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
14. Integration of ultrasound radiomics features and clinical factors: A nomogram model for identifying the Ki-67 status in patients with breast carcinoma.
Wu J; Fang Q; Yao J; Ge L; Hu L; Wang Z; Jin G
Front Oncol; 2022; 12():979358. PubMed ID: 36276108
[TBL] [Abstract][Full Text] [Related]
15. Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer.
Gao L; Jiang W; Yue Q; Ye R; Li Y; Hong J; Zhang M
Int Immunopharmacol; 2022 Dec; 113(Pt A):109335. PubMed ID: 36279669
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma.
Wu J; Ge L; Jin Y; Wang Y; Hu L; Xu D; Wang Z
Front Oncol; 2022; 12():993466. PubMed ID: 36530981
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Computed Tomography-Based Radiomics Nomogram for the Preoperative Prediction of Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
Mou Y; Han X; Li J; Yu P; Wang C; Song Z; Wang X; Zhang M; Zhang H; Mao N; Song X
Acad Radiol; 2024 May; 31(5):1805-1817. PubMed ID: 38071100
[TBL] [Abstract][Full Text] [Related]
18. MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.
Li Q; Xiao Q; Li J; Duan S; Wang H; Gu Y
Cancer Manag Res; 2020; 12():10603-10613. PubMed ID: 33149669
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.
Xu A; Chu X; Zhang S; Zheng J; Shi D; Lv S; Li F; Weng X
BMC Cancer; 2022 Aug; 22(1):872. PubMed ID: 35945526
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-based radiomics combined with immune status to predict sentinel lymph node metastasis in primary breast cancer.
Zhao M; Zheng Y; Chu J; Liu Z; Dong F
Sci Rep; 2023 Oct; 13(1):16918. PubMed ID: 37805562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
